Dergiler / Medicine Science / 2021 / Cilt: 10 - Sayı: 2

Genotype distribution in chronic hepatitis C, relationship of genotype with HCV RNA, alpha fetoprotein, alanine aminotransferase and liver fibrosis

Sayfa
605–608
Yayın Tarihi
2022-10-18
DOI
—
🏛️Bu makalenin bibliyografik verileri ve tam metin bağlantısı DergiPark üzerinden sağlanmıştır.
DergiPark Kaydı ↗
✨

Yapay Zeka Hızlı Bakış & Çıkarımlar

AI Insight
⚡ TL;DR(1 Cümlede Hızlı Çıkarım)

Such studies may be important in epidemiological evaluation of HCI’s and follow-up of genotype profile changes.

📌 3 Maddede Bu Makale

🎯
Amaç & Hipotez:In this study, the genotype distribution in chronic hepatitis C (CHC) and its relationship with alanine aminotransferase (ALT), alpha fetoprotein (AFP), HCV RNA and liver fibrosis were compared.
📊
Temel Bulgular & Veri:HCV RNA was negative in 63 and positive in 69 CHC cases who applied to the infectious diseases outpatient clinic between May 2016 and June 2018 were included in the study.
💡
Sonuç & Katkı:Such studies may be important in epidemiological evaluation of HCI’s and follow-up of genotype profile changes.
🔬Tür:Araştırma Makalesi
📍Kapsam:2016 Verileri
⚙️Değişkenler:Alan Parametreleri

Abstract

In this study, the genotype distribution in chronic hepatitis C (CHC) and its relationship with alanine aminotransferase (ALT), alpha fetoprotein (AFP), HCV RNA and liver fibrosis were compared. HCV RNA was negative in 63 and positive in 69 CHC cases who applied to the infectious diseases outpatient clinic between May 2016 and June 2018 were included in the study. Demographic data, laboratory and pathology results of the cases were evaluated retrospectively. 76 of the cases were male, 56 of them were female. In HCV RNA positive cases, Serum ALT and AFP level were statistically significantly higher than negative ones (p: 0.04, p: 0.001). Of HCV RNA positive cases, genotype 1b in 42 (60.9%), 3a in 10 (14.5%), 1a in 8 (11.6%), 4d in 5 (7.2%), and 2b in 4 (5.8%) were found. There was no statistically significant difference between genotypes in terms of HCV RNA, ALT and fibrosis. AFP level was statistically significantly higher in genotype 1b than other genotypes. Consistent with studies, the most common genotype was 1b. One of the main results is that there is no significant relationship between genotype difference and ALT, AFP and HCV RNA and fibrosis in CHC cases. Therefore, although these parameters may play a role in chronicity and inflammation, they may not be sufficient in the evaluation of fibrosis. High level of AFP in genotype 1b compared to other genopes may be useful in determining prognosis. Such studies may be important in epidemiological evaluation of HCI’s and follow-up of genotype profile changes.

🔖

Bu Makaleye Atıf Yap

Aytac, O., Senol, A. (2022). Genotype distribution in chronic hepatitis C, relationship of genotype with HCV RNA, alpha fetoprotein, alanine aminotransferase and liver fibrosis. Medicine Science, Cilt: 10 - Sayı: 2, 605–608. https://ajindex.com/articles/579661

📄 Tam Metin PDF Okuyucu

📄

PDF görüntüleyici hazırlanıyor...

Kaynakça (13)

  1. Kuo MT, Hu TH, Lu SN, et al. Neutrophil-to-lymphocyte ratio as a predictor of response to peginterferon plus ribavirin therapy for chronic hepatitis C. Dis Markers. 2014;2014:1-17.
  2. Shahid M, Idrees M, Nasir B, et al. Correlation of biochemical markers and HCV RNA titers with fibrosis stages and grades in chronic HCV-3a patients. Eur J Gastroenterol Hepatol. 2014;26:788-94.
  3. Nar R, Sezgin MF. The relationship between the serum RNA titers of hepatitis C Virus and Biochemical Parameters in Chronic Hepatitis C Patients. Viral Hepatitis J. 2016;22:28-33.
  4. Chen Y, Yu C, Yin X, et al. Hepatitis C virus genotypes and subtypes circulating in Mainland China Emerging Microbes & Infections. 2017;6:95. Zeytinli ÜO, Yücel FM, Dinçer ŞD, et al. Distribution of hepatitis C virus genotypes in the region of i̇stanbul northern anatolian association of public hospitals. Viral Hepatitis J. 2017;23:10-3.
  5. Caliskan A, Kirisci O, Ozkaya E, et al. Distribution and predominance of genotype 3 in hepatitis C virus carriers in the province of Kahramanmaras, Turkey. Hepat Mon. 2015;15:25142. Altuğlu I, Sertoz R, Aksoy A, et al. Possible transmission risks and genotype distribution of hepatitis C virus infection in Western Turkey. Turk J Gastroenterol. 2013;24:349-55.
  6. Marinho RT, Vitor S, Velosa J. Benefits of curing hepatitis C infection. J Gastrointestin Liver Dis. 2014;23:85-90.
  7. Saludes V, González V, Planas R, et al. Tools for the diagnosis of hepatitis C virus infection and hepatic fibrosis staging. World J Gastroenterol. 2014;20:3431-42.
  8. Ishak K, Baptista A, Bianchi L, et al. Histological grading and staging of chronic hepatitis. J Hepatol. 1995;22:696–9.
  9. Li HC, Lo SY. Hepatitis C virus: Virology, diagnosis and treatment. World J Hepatol. 2015;7:1377-89.
  10. Harman R, Günal Ö, Özger S. Gaziantep bölgesindeki kronik hepatit C hastalarında hepatit C virusu genotip dağılımı. Klimik Dergisi. 2017;30:68- 70. Aydemir Ö, Demiray T, Koroğlu M, et al. Hepatitis C prevalence in different age groups; people over 50 years of age may receive one-time testing for ti-HCV. Viral Hepatitis J. 2015;21:40-3.
  11. Bruggmann P, Berg T, Øvrehus AL, et al. Historical epidemiology of hepatitis C virus (HCV) in selected countries. J Viral Hepat. 2014; 21(Suppl. 1):5-33.
  12. Tozun N, Ozdogan O, Cakaloglu Y, et al. Seroprevalance of hepatitis B and C virus infections and risk factors in Turkey: a fieldwork TURHEP study. Clin Microbiol Infect. 2015;21:1020-6.
  13. Küçüköztaş MF, Özgüneş N, Yazıcı S. Kronik hepatit C’li hastalard